Pediatric soft tissue sarcomas

被引：91

作者：

Loeb, David M. ^{[1
]}

Thornton, Katherine ^{[1
]}

Shokek, Ori ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Musculoskeletal Tumor Program, Baltimore, MD 21231 USA

来源：

SURGICAL CLINICS OF NORTH AMERICA | 2008年 / 88卷 / 03期

关键词：

D O I：

10.1016/j.suc.2008.03.008

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Soft tissue sarcomas in children are rare. Approximately 850 to 900 children and adolescents are diagnosed each year with rhabdomyosarcoma (RMS) or a non-RMS soft tissue sarcoma (NRSTS). RMS is more common in children 14 years old and younger and NRSTS in adolescents and young adults. Infants get NRSTS, but their tumors constitute a distinctive set of histologies. Surgery is a major therapeutic modality and radiation plays a role. RMS is treated with adjuvant chemotherapy, whereas chemotherapy is reserved for the NRSTS that are high grade or unresectable. This review discusses the etiology, biology, and treatment of pediatric soft tissue sarcomas.

引用

页码：615 / +

页数：14

共 35 条

[1] DIAGNOSIS OF SOFT-TISSUE TUMORS BY TRU-CUT BIOPSY [J].

BALL, ABS ;

FISHER, C ;

PITTAM, M ;

WATKINS, RM ;

WESTBURY, G .

BRITISH JOURNAL OF SURGERY, 1990, 77 (07) :756-758

[2]

BARTH RJ, 1992, SURGERY, V112, P536

[3] Medical progress: Soft-tissue sarcomas in adults [J].

Clark, MA ;

Fisher, C ;

Judson, I ;

Thomas, JM .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (07) :701-711

[4] Amputation for soft-tissue sarcoma [J].

Clark, MA ;

Thomas, JM .

LANCET ONCOLOGY, 2003, 4 (06) :335-342

[5] Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma [J].

Davis, AM ;

O'Sullivan, B ;

Turcotte, R ;

Bell, R ;

Catton, C ;

Chabot, P ;

Wunder, J ;

Hammond, A ;

Benk, V ;

Kandel, R ;

Goddard, K ;

Zee, B ;

Day, A ;

Tu, DS ;

Pater, J .

RADIOTHERAPY AND ONCOLOGY, 2005, 75 (01) :48-53

[6] Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma [J].

Davis, AM ;

O'Sullivan, B ;

Bell, RS ;

Turcotte, R ;

Catton, CN ;

Wunder, JS ;

Chabot, P ;

Hammond, A ;

Benk, V ;

Isler, M ;

Freeman, C ;

Goddard, K ;

Bezjak, A ;

Kandel, RA ;

Sadura, A ;

Day, A ;

James, K ;

Tu, D ;

Pater, J ;

Zee, B .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (22) :4472-4477

[7] Rhabdomyosarcoma: Many similarities, a few philosophical differences [J].

Donaldson, SS ;

Anderson, JR .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2586-2587

[8] Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma - A report from the IRSG [J].

Donaldson, SS ;

Meza, J ;

Breneman, JC ;

Crist, WM ;

Laurie, F ;

Qualman, SJ ;

Wharam, M .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (03) :718-728

[9] RANDOMIZED COMPARISON OF DOXORUBICIN ALONE VERSUS IFOSFAMIDE PLUS DOXORUBICIN OR MITOMYCIN, DOXORUBICIN, AND CISPLATIN AGAINST ADVANCED SOFT-TISSUE SARCOMAS [J].

EDMONSON, JH ;

RYAN, LM ;

BLUM, RH ;

BROOKS, JSJ ;

SHIRAKI, M ;

FRYTAK, S ;

PARKINSON, DR .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1269-1275

[10] Validation of the postoperative nomogram for 12-year sarcoma-specific mortality [J].

Eilber, FC ;

Brennan, MF ;

Eilber, FR ;

Dry, SM ;

Singer, S ;

Kattan, MW .

CANCER, 2004, 101 (10) :2270-2275

← 1 2 3 4 →